Amgen Inc. (AMGN) Revenue 2016–2025
Amgen Inc. (AMGN) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$36.8BFY2025 · since FY2016: $23.0B → $36.8B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $36.8B | +10.0% |
| FY2024 | $33.4B | +18.6% |
| FY2023 | $28.2B | +7.1% |
| FY2022 | $26.3B | +1.3% |
| FY2021 | $26.0B | +2.2% |
| FY2020 | $25.4B | +8.8% |
| FY2019 | $23.4B | -1.6% |
| FY2018 | $23.7B | +3.9% |
| FY2017 | $22.8B | -0.6% |
| FY2016 | $23.0B | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More AMGN financial trends
AMGN Net incomeAMGN Net marginAMGN Gross profitAMGN Gross marginAMGN Operating incomeAMGN Operating marginAMGN Operating cash flowAMGN Free cash flowAMGN Capital expendituresAMGN Return on equityAMGN Stock buybacksAMGN Dividends paidAMGN Total assetsAMGN Total liabilitiesAMGN Shareholders’ equityAMGN overview →